Glycyrrhizin alleviates liver injury by precisely inhibiting the overactivation of this pathway in normal hepatocytes, which reverses cell cycle blockade and restores normal hepatocyte proliferation and function through downregulating p53/p21 and upregulating Cyclin D1, all without compromising the antitumor efficacy of gefitinib via the same pathway in cancer cells ( 4.7 Glycyrrhizin and other hepatoprotective agents A variety of hepatoprotective agents are currently used in clinical practice, including silymarin, N-acetylcysteine (NAC), ursodeoxycholic acid (UDCA), as well as polyene phosphatidylcholine (PPC), bicyclol, S-adenosylmethionine (SAMe), and glucocorticoids
Deductible: This is an annual amount a person must spend out of pocket within a certain period before Medicare starts to fund their treatments
Reduced glutathione (GSH)
PubMed laboratory research record [PMID: 11376200] PubMed record related to this compound for laboratory literature review
Separately, we speculated that GGT1 is sufficient to support the breakdown of GSH in the extracellular environment